Compounds > betamethasone-17,21-dipropionate

Page last updated: 2024-08-22

betamethasone-17,21-dipropionate and Dermatitis, Exfoliative

betamethasone-17,21-dipropionate has been researched along with Dermatitis, Exfoliative in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lassus, A; Salde, L	1
Arbiser, JL; Arndt, KA; Grossman, K; Kaye, E	1

Trials

1 trial(s) available for betamethasone-17,21-dipropionate and Dermatitis, Exfoliative

Article	Year
Systemic side-effects of three topical steroids in diseased skin. Current medical research and opinion, 1983, Volume: 8, Issue:7 Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Budesonide; Clinical Trials as Topic; Dermatitis, Exfoliative; Female; Glucocorticoids; Humans; Male; Middle Aged; Pregnenediones; Psoriasis	1983

Other Studies

1 other study(ies) available for betamethasone-17,21-dipropionate and Dermatitis, Exfoliative

Article	Year
Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis. Archives of dermatology, 1994, Volume: 130, Issue:6 Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Exfoliative; Female; Glucocorticoids; Humans; Male; Middle Aged; Occlusive Dressings; Psoriasis; Time Factors	1994